NEOLEUKIN THERAPEUTICS INC's ticker is NLTX and the CUSIP is 64049K104. A total of 82 filers reported holding NEOLEUKIN THERAPEUTICS INC in Q4 2021. The put-call ratio across all filers is 0.16 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $137 | -86.3% | 270 | -65.7% | 0.00% | – |
| Q3 2022 | $1,000 | 0.0% | 788 | -36.0% | 0.00% | – |
| Q2 2022 | $1,000 | -85.7% | 1,231 | -67.9% | 0.00% | – |
| Q1 2022 | $7,000 | -85.7% | 3,832 | -62.6% | 0.00% | – |
| Q4 2021 | $49,000 | 0.0% | 10,253 | +51.4% | 0.00% | – |
| Q3 2021 | $49,000 | -91.0% | 6,773 | -88.6% | 0.00% | – |
| Q2 2021 | $547,000 | -49.5% | 59,211 | -32.7% | 0.00% | -100.0% |
| Q1 2021 | $1,084,000 | +885.5% | 88,019 | +1024.3% | 0.00% | – |
| Q4 2020 | $110,000 | +400.0% | 7,829 | +328.3% | 0.00% | – |
| Q3 2020 | $22,000 | -84.8% | 1,828 | -79.1% | 0.00% | – |
| Q2 2020 | $145,000 | +806.2% | 8,762 | +525.9% | 0.00% | – |
| Q1 2020 | $16,000 | -79.5% | 1,400 | -77.9% | 0.00% | – |
| Q4 2019 | $78,000 | +457.1% | 6,349 | +27.0% | 0.00% | – |
| Q3 2019 | $14,000 | – | 5,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Opaleye Management Inc. | 1,386,300 | $19,547,000 | 2.55% |
| EcoR1 Capital, LLC | 3,122,704 | $44,030,000 | 2.37% |
| Redmile Group, LLC | 4,131,869 | $58,259,000 | 0.70% |
| Boxer Capital, LLC | 1,501,058 | $21,165,000 | 0.68% |
| HighVista Strategies LLC | 69,727 | $983,000 | 0.63% |
| Baker Brothers Advisors | 3,821,740 | $53,887,000 | 0.20% |
| Highland Private Wealth Management | 93,998 | $1,326,000 | 0.12% |
| Sio Capital Management, LLC | 38,312 | $540,000 | 0.11% |
| Point72 Asset Management, L.P. | 1,195,725 | $16,860,000 | 0.08% |
| Granahan Investment Management | 246,299 | $3,473,000 | 0.08% |